Many studies have discussed the interactions between AR signaling and other molecular pathways in prostate cancer progression, highlighting the potential for combination therapies to enhance treatment efficacy and overcome resistance mechanisms [27,29-33]. This evidence concerns the gene AR and prostate cancer.